The new website promises “low cost prescription drugs,” but will not prescribe or sell drugs directly to the patient
:max_bytes(150000):strip_icc():format(jpeg)/Donald-Trump-Melania-premiere-2026-020526-01caa907b39a4c8d877bc9c524e59259.jpg)
Dimitrios Kambouris/Getty
NEED TO KNOW
- The Trump administration has announced that its discount drug platform, TrumpRx, will launch on Thursday, Feb. 5
- Press secretary Karoline Leavitt called it a “state of the art website” for “low cost prescription drugs”
- Experts say it’ll help a narrow group of people, citing “no clear advantage for most people” to use the platform
The Trump administration announced that its discount drug platform, TrumpRx, will launch Thursday, Feb. 5, at 7 p.m.
President Donald Trump, Centers for Medicare and Medicaid Services administrator Dr. Mehmet Oz, and Airbnb co-founder Joe Gebbia, who oversees the National Design Studio, which designs federal websites, are expected to unveil the website together.
In a post on X, press secretary Karoline Leavitt described the site as “a state of the art website for Americans consumers to purchase low cost prescription drugs. This historic announcement will save millions of Americans money. You won’t want to miss it!”
The site — currently showing a countdown clock and little pills that can be moved around the page by the user — will not prescribe or sell drugs directly, but rather is a portal where patients with an existing prescription can navigate to the medications’ specific websites to buy them, per The New York Times.
TrumpRx.gov
The administration made deals with at least 16 manufacturers, NBC News reported. While the full list of available medications has not been released, some available via TrumpRx are expected to include Januvia, a diabetes drug from Merck; Repatha, a cholesterol-lowering drug; and the popular GLP-1 weight-loss medications Wegovy, from Novo Nordisk, and Zepbound, from Eli Lilly, per NBC News.
The administration previously announced a deal to offer the GLP-1 medications for as low as $149 a month. Other prices, per examples cited by the NYT, vary widely, with the blood thinner Plavix costing $16 a month, and Epclusa, a 12-week treatment for hepatitis C, carrying a $2,425 price tag.
Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
The administration has touted a "most favored nation" pricing model — meaning the U.S. shouldn’t pay more than other countries pay for the same medication. U.S. patients can spend up to three times more than other developed countries for the same medication, Reuters reported. However, those 16 companies — and others — all raised prices in January, according to NPR, citing data from drug price research firm 46 Brooklyn.
The TrumpRx model may save money for those who are paying out-of-pocket, but not offer much benefit for those with private insurance or Medicaid, NBC News reported in January.
“TrumpRx might support access and affordability for a very small number of people,” Rena Conti, an associate professor at the Boston University Questrom School of Business, told CNN.
“There’s no clear advantage for most people to use TrumpRx to purchase their medications," Juliette Cubanski, deputy director of the program on Medicare Policy at KFF, told NBC News.
Read the full article here
